1. Home
  2. CNVS vs CING Comparison

CNVS vs CING Comparison

Compare CNVS & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cineverse Corp.

CNVS

Cineverse Corp.

HOLD

Current Price

$2.48

Market Cap

54.7M

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$3.94

Market Cap

59.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNVS
CING
Founded
2000
2012
Country
United States
United States
Employees
N/A
14
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.7M
59.3M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
CNVS
CING
Price
$2.48
$3.94
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$9.00
$34.50
AVG Volume (30 Days)
132.3K
438.1K
Earning Date
02-17-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
108.99
N/A
EPS
N/A
N/A
Revenue
$78,181,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$84.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
59.13
N/A
52 Week Low
$1.77
$3.20
52 Week High
$7.39
$11.89

Technical Indicators

Market Signals
Indicator
CNVS
CING
Relative Strength Index (RSI) 46.76 35.11
Support Level $2.31 $3.50
Resistance Level $2.67 $4.16
Average True Range (ATR) 0.11 0.46
MACD -0.01 -0.01
Stochastic Oscillator 21.21 3.31

Price Performance

Historical Comparison
CNVS
CING

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: